Expired Tender Belgium ICB TOT Ref. 49934098

Supply of Bevacizumab 100 Mg / 4 Ml and 400 Mg Tender - 49934098

Tender notice from Belgium, published on 06 Feb 2021.

Executive Summary

The UNIVERSITY HOSPITALS LEUVEN has issued a Tender notice for the procurement of a Supply of Bevacizumab 100 Mg / 4 Ml and 400 Mg / 16 Ml for Intravenous Use in the Belgium. This Tender notice was published on 06 Feb 2021 and is scheduled to close on 18 Feb 2021, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 49934098, while the tender notice number is 058895-2021 and Register on the platform.

Key facts

Summary
Supply of Bevacizumab 100 Mg / 4 Ml and 400 Mg / 16 Ml for Intravenous Use
TOT Ref. No.
49934098
Document Ref. No.
058895-2021
Country
Belgium
Notice type
Tender
Competition
ICB
Publication date
06 Feb 2021
Bid deadline
18 Feb 2021
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Document Type: Contract notice
Title: Supply of bevacizumab 100 mg / 4 ml and 400 mg / 16 ml for intravenous use
Reference Number: UZ Leuven-P6898-F02_0
Contract Type: Supplies
Description: In order to be able to meet the continuous and, if necessary, urgent needs, the client wishes to conclude a multilateral framework agreement in accordance with Article 43 of the Public Procurement Act of 17.6.2016.
The subject of the contract concerns the supply of the following medicines: the supply of bevacizumab 100 mg / 4 ml and 400 mg / 16 ml for intravenous use to the hospital pharmacy.
The medicine in question must in any case be registered / licensed for marketing in BELGIUM in accordance with the relevant legislation.
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33652000 - Antineoplastic and immunomodulating agents
Authority Type: Other
Type of Procedure: Competitive procedure with negotiation
Regulation: European Union
Bid Type: Submission for all lots
Doc Title: General anti-infectives for systemic use, vacci ...

Documents

Tender Notice
Login to view

Similar tenders

Belgium Public Procurement Intelligence

Frequently asked questions

The bid deadline for Supply of Bevacizumab 100 Mg / 4 Ml and 400 Mg / 16 Ml for Intravenous Use was 18 Feb 2021. Bidding is closed.

This tender has been issued by UNIVERSITY HOSPITALS LEUVEN in Belgium.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33652000 - Antineoplastic and immunomodulating agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 49934098. The purchaser document reference is 058895-2021.

See the Similar Tenders section on this page or browse other tenders from Belgium.

This tender falls under Materials and Products, Technology and Equipment in Belgium. Suppliers in these sectors can track similar Belgium tenders using CPV-based alerts.